119 related articles for article (PubMed ID: 20466145)
1. The binding of vinca domain agents to tubulin: structural and biochemical studies.
Cormier A; Knossow M; Wang C; Gigant B
Methods Cell Biol; 2010; 95():373-90. PubMed ID: 20466145
[TBL] [Abstract][Full Text] [Related]
2. Structural plasticity of tubulin assembly probed by vinca-domain ligands.
Ranaivoson FM; Gigant B; Berritt S; Joullié M; Knossow M
Acta Crystallogr D Biol Crystallogr; 2012 Aug; 68(Pt 8):927-34. PubMed ID: 22868758
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for the regulation of tubulin by vinblastine.
Gigant B; Wang C; Ravelli RB; Roussi F; Steinmetz MO; Curmi PA; Sobel A; Knossow M
Nature; 2005 May; 435(7041):519-22. PubMed ID: 15917812
[TBL] [Abstract][Full Text] [Related]
4. Interaction of vinca alkaloids with tubulin: a comparison of vinblastine, vincristine, and vinorelbine.
Lobert S; Vulevic B; Correia JJ
Biochemistry; 1996 May; 35(21):6806-14. PubMed ID: 8639632
[TBL] [Abstract][Full Text] [Related]
5. Fluorescence spectroscopic methods to analyze drug-tubulin interactions.
Bhattacharyya B; Kapoor S; Panda D
Methods Cell Biol; 2010; 95():301-29. PubMed ID: 20466142
[TBL] [Abstract][Full Text] [Related]
6. Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain.
Ravelli RB; Gigant B; Curmi PA; Jourdain I; Lachkar S; Sobel A; Knossow M
Nature; 2004 Mar; 428(6979):198-202. PubMed ID: 15014504
[TBL] [Abstract][Full Text] [Related]
7. Insight into the GTPase activity of tubulin from complexes with stathmin-like domains.
Wang C; Cormier A; Gigant B; Knossow M
Biochemistry; 2007 Sep; 46(37):10595-602. PubMed ID: 17711308
[TBL] [Abstract][Full Text] [Related]
8. Structural insight into the inhibition of tubulin by vinca domain peptide ligands.
Cormier A; Marchand M; Ravelli RB; Knossow M; Gigant B
EMBO Rep; 2008 Nov; 9(11):1101-6. PubMed ID: 18787557
[TBL] [Abstract][Full Text] [Related]
9. QM and QM/MD simulations of the Vinca alkaloids docked to tubulin.
Kelly EB; Tuszynski JA; Klobukowski M
J Mol Graph Model; 2011 Sep; 30():54-66. PubMed ID: 21798777
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic selectivity of vinca alkaloids: a role for guanosine 5'-triphosphate?
Houghton PJ; Houghton JA; Bowman LC; Hazelton BJ
Anticancer Drug Des; 1987 Oct; 2(2):165-79. PubMed ID: 3329524
[TBL] [Abstract][Full Text] [Related]
11. Linkages in tubulin-colchicine functions: the role of the ring C (C') oxygens and ring B in the controls.
Pérez-Ramírez B; Gorbunoff MJ; Timasheff SN
Biochemistry; 1998 Feb; 37(6):1646-61. PubMed ID: 9484236
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of vinca alkaloids and phomopsin hybrids.
Ngo QA; Roussi F; Cormier A; Thoret S; Knossow M; Guénard D; Guéritte F
J Med Chem; 2009 Jan; 52(1):134-42. PubMed ID: 19072542
[TBL] [Abstract][Full Text] [Related]
13. Tubulin-based structure-affinity relationships for antimitotic Vinca alkaloids.
Coderch C; Morreale A; Gago F
Anticancer Agents Med Chem; 2012 Mar; 12(3):219-25. PubMed ID: 22044006
[TBL] [Abstract][Full Text] [Related]
14. Vinca site agents induce structural changes in tubulin different from and antagonistic to changes induced by colchicine site agents.
Sackett DL
Biochemistry; 1995 May; 34(21):7010-9. PubMed ID: 7766610
[TBL] [Abstract][Full Text] [Related]
15. Structure-based identification of the binding site for the hemiasterlin analogue HTI-286 on tubulin.
Ravi M; Zask A; Rush TS
Biochemistry; 2005 Dec; 44(48):15871-9. PubMed ID: 16313189
[TBL] [Abstract][Full Text] [Related]
16. N-terminal stathmin-like peptides bind tubulin and impede microtubule assembly.
Clément MJ; Jourdain I; Lachkar S; Savarin P; Gigant B; Knossow M; Toma F; Sobel A; Curmi PA
Biochemistry; 2005 Nov; 44(44):14616-25. PubMed ID: 16262261
[TBL] [Abstract][Full Text] [Related]
17. Stathmin and interfacial microtubule inhibitors recognize a naturally curved conformation of tubulin dimers.
Barbier P; Dorléans A; Devred F; Sanz L; Allegro D; Alfonso C; Knossow M; Peyrot V; Andreu JM
J Biol Chem; 2010 Oct; 285(41):31672-81. PubMed ID: 20675373
[TBL] [Abstract][Full Text] [Related]
18. Binding of dolastatin 10 to tubulin at a distinct site for peptide antimitotic agents near the exchangeable nucleotide and vinca alkaloid sites.
Bai RL; Pettit GR; Hamel E
J Biol Chem; 1990 Oct; 265(28):17141-9. PubMed ID: 2211617
[TBL] [Abstract][Full Text] [Related]
19. Theoretical insight into the structural mechanism for the binding of vinblastine with tubulin.
Chi S; Xie W; Zhang J; Xu S
J Biomol Struct Dyn; 2015; 33(10):2234-54. PubMed ID: 25588192
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the interaction of cryptophycin 1 with tubulin: binding in the Vinca domain, competitive inhibition of dolastatin 10 binding, and an unusual aggregation reaction.
Bai R; Schwartz RE; Kepler JA; Pettit GR; Hamel E
Cancer Res; 1996 Oct; 56(19):4398-406. PubMed ID: 8813133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
